Dostarlimab. Anti-PD-1 monoclonal antibody, Treatment of advanced solid tumors

K Haddley - Drugs of the Future, 2019 - access.portico.org
Programmed cell death protein 1 (PD-1) receptor is expressed on the surface of T cells.
Tumor antigen-presenting cells express programmed cell death 1 ligand 1 (PD-L1) …